Diagnosis of cardiac sarcoidosis: An imperfect science, a hesitant art

Chest

Volumn 123, Issue 1, 2003, Pages 18-19

  Sharma, Om P ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GADOLINIUM PENTETATE; GALLIUM 67; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; RADIOISOTOPE; THALLIUM 201;

ANGIOCARDIOGRAPHY; AUTOPSY; CLINICAL FEATURE; CLINICAL TRIAL; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG EFFICACY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAM; HEART MUSCLE BIOPSY; HOLTER MONITORING; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SAFETY; SARCOIDOSIS; SENSITIVITY ANALYSIS; SUPRAVENTRICULAR PREMATURE BEAT; SURVIVAL TIME;

EID: 0037248670     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1.18     Document Type: Editorial

References (25)

1. Bernstein M, Konzelmann F, Sidlick D. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929; 44:721-734
2. Cozo E, Cosnow I, Cohen H. The heart in sarcoidosis. Chest 1971; 60:379-388
3. Hagemann G, Wurm K. Be alert to heart involvement in sarcoidosis. Med Klin 1980; 75:655-669
4. Thomsen K, Ericksson T. Myocardial sarcoidosis in forensic medicine. Am J Forensic Med Pathol 1999; 20:52-56
5. Silverman K, Hutchins G, Bulkley B. Cardiac sarcoidosis: a clinico-pathological study of 84 in selected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211
6. Iwai K, Selkiguchi M, Hosoda Y, et al. Racial differences in cardiac sarcoidosis observed at autopsy. Sarcoidosis 1994; 11:26-31
7. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173
8. Roberts W, McAllister H, Ferrans V. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63:86-108
9. Flemming H, Bailey S. Cardiac sarcoidosis. In: James DG, ed. Sarcoidosis and other granulomatous disorders (vol 73). New York, NY: Marcel Dekker, 1994; 323-334
10. Paz H, McCormick D, Kutalek S, et al. The automatic implantable defibrillator prophylaxis in cardiac sarcoidosis. Chest 1994; 106:1603-1607
11. Baughman R. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med 2002; 8:464-469
12. Suzuki T, Tsugiyasu K, Kubata S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994; 106:1021-1024
13. Burstow D, Tajik A, Barley K, et al. Two-dimensional echo-cardiographic findings in systemic sarcoidosis. Am J Cardiol 1989; 63:478-482
14. Haywood J, Sharma O, Siegel M. Detection of myocardial sarcoidosis by thallium-201 imaging. J Natl Med Assoc 1983; 63:478-482
15. Fields G, Ossorio M, Roy T, et al. Thallium 201 scintigraphy in the diagnosis the management of myocardial sarcoidosis. South Med J 1990; 83:339-342
16. Jellier P, Paycha F, Antony I. Reversibility by dipyridamole of thallium-201 myocardial defects in patients with sarcoidosis. Am J Med 1988; 85:189-193
17. Mana J. Nuclear imaging: 67 Gallium, 201 thallium, 18 F labeled fluoro-2 deoxy-D glucose position emission tomography. Clin Chest Med 1997; 18:799-811
18. Kinney E, Caldwell J. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 1990: 41:573-576
19. Okayama K, Kurata C, Tawarahara K. Diagnostic and prognostic value of myocardial scintigraphy with thallium 201 and gallium 67 in cardiac sarcoidosis. Chest 1995; 107:330-334
20. Hirose Y, Ishida Y, Hayashida K. Myocardial involvement in patients with sarcoidosis: an analysis of 75 patients. Clin Nucl Med 1994; 19:522-526
21. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000; 55:323-325
22. Inoue S, Shimada T, Murakami Y. Clinical significance of gadolium-DTPA enhancement MRI for detection of myocardial lesion in a patient with sarcoidosis. Clin Radiol 1999; 54:70-72
23. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110:520-527
24. Vignaux C, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002; 122:1895-1901
25. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endocardial biopsies. Am Heart J 1999; 138:299-302